Liver graft preservation and functional maintenance accelerate the development of liver transplantation

Xie Yan; Jiang Wentao

doi:10.3969/j.issn.1674-7445.2023.02.004

Volume 14 Issue 2

Mar. 2023

Turn off MathJax

Article Contents

Article Navigation > ORGAN TRANSPLANTATION > 2023 > 14(2): 201-206

Xie Yan, Jiang Wentao. Liver graft preservation and functional maintenance accelerate the development of liver transplantation[J]. ORGAN TRANSPLANTATION, 2023, 14(2): 201-206. doi: 10.3969/j.issn.1674-7445.2023.02.004

Citation:

PDF( 1216 KB)

Liver graft preservation and functional maintenance accelerate the development of liver transplantation

doi: 10.3969/j.issn.1674-7445.2023.02.004

Xie Yan,
Jiang Wentao^,

Department of Liver Transplantation, Tianjin First Center Hospital, Tianjin Key Laboratory for Organ Transplantation, Research Institute of Transplant Medicine, Nankai University, Tianjin 300190, China

More Information

Corresponding author: Jiang Wentao, Email: jiangwentao@nankai.edu.cn
Received Date: 2023-01-29
Available Online: 2023-03-15
Publish Date: 2023-03-15

Abstract

Abstract

As an effective treatment for end-stage liver disease, liver transplantation has been widely carried out worldwide and gradually captivated widespread recognition. With the advancement of liver transplantation techniques, the incidence of postoperative complications has been gradually declined, and the short-term and long-term prognosis of recipients have been constantly improved. However, a huge gap has existed between the supply and demand of donor organs, which is a major factors restricting the development of liver transplantation. The amount of liver transplantation operation in China is increasing year by year, the shortage of donor liver is becoming more and more prominent, and marginal donor liver is increasingly used in clinic. In recent years, the selection criteria of donor organs, organ preservation and functional maintenance have been continuously improved. In this article, the application and development trend of different techniques were reviewed from the perspectives of donor liver preservation and functional maintenance, and recent technical development and research results were summarized, aiming to provide reference for further enhancing the survival rate of grafts and recipients and promoting the development of liver transplantation in China.
- Liver transplantation,
- Marginal liver graft,
- Static cold storage,
- Machine perfusion,
- Ischemia-reperfusion injury,
- Functional maintenance,
- Gene therapy,
- Stem cell therapy

FullText(HTML)

References(35)

References

[1]	LIN Y, HUANG H, CHEN L, et al. Assessing donor liver quality and restoring graft function in the era of extended criteria donors[J]. J Clin Transl Hepatol, 2023, 11(1): 219-230. DOI: 10.14218/JCTH.2022.00194.
[2]	XIA C, DONG X, LI H, et al. Cancer statistics in China and United States, 2022: profiles, trends, and determinants[J]. Chin Med J (Engl), 2022, 135(5): 584-590. DOI: 10.1097/CM9.0000000000002108.
[3]	CHEN Z, HONG X, HUANG S, et al. Continuous normothermic machine perfusion for renovation of extended criteria donor livers without recooling in liver transplantation: a pilot experience[J]. Front Surg, 2021, 8: 638090. DOI: 10.3389/fsurg.2021.638090.
[4]	PESCARISSI C, PENZO B, GHINOLFI D, et al. The perioperative period of liver transplantation from unconventional extended criteria donors: data from two high-volume centres[J]. BMC Anesthesiol, 2022, 22(1): 390. DOI: 10.1186/s12871-022-01932-x.
[5]	AMIN A, PANAYOTOVA G, GUARRERA JV. Hypothermic machine perfusion for liver graft preservation[J]. Curr Opin Organ Transplant, 2022, 27(2): 98-105. DOI: 10.1097/MOT.0000000000000973.
[6]	JAKUBAUSKAS M, JAKUBAUSKIENE L, LEBER B, et al. Machine perfusion in liver transplantation: a systematic review and meta-analysis[J]. Visc Med, 2022, 38(4): 243-254. DOI: 10.1159/000519788.
[7]	JOCHMANS I, BRAT A, DAVIES L, et al. Oxygenated versus standard cold perfusion preservation in kidney transplantation (COMPARE): a randomised, double-blind, paired, phase 3 trial[J]. Lancet, 2020, 396(10263): 1653-1662. DOI: 10.1016/S0140-6736(20)32411-9.
[8]	TINGLE SJ, FIGUEIREDO RS, MOIR JA, et al. Machine perfusion preservation versus static cold storage for deceased donor kidney transplantation[J]. Cochrane Database Syst Rev, 2019, 3(3): CD011671. DOI: 10.1002/14651858.CD011671.pub2.
[9]	BARDALLO RG, DA SILVA RT, CARBONELL T, et al. Liver graft hypothermic static and oxygenated perfusion (HOPE) strategies: a mitochondrial crossroads[J]. Int J Mol Sci, 2022, 23(10): 5742. DOI: 10.3390/ijms23105742.
[10]	SCHLEGEL A, MULLER X, MUELLER M, et al. Hypothermic oxygenated perfusion protects from mitochondrial injury before liver transplantation[J]. EBioMedicine, 2020, 60: 103014. DOI: 10.1016/j.ebiom.2020.103014.
[11]	MUGAANYI J, DAI L, LU C, et al. A meta-analysis and systematic review of normothermic and hypothermic machine perfusion in liver transplantation[J]. J Clin Med, 2022, 12(1): 235. DOI: 10.3390/jcm12010235.
[12]	SOUSA DA SILVA RX, WEBER A, DUTKOWSKI P, et al. Machine perfusion in liver transplantation[J]. Hepatology, 2022, 76(5): 1531-1549. DOI: 10.1002/hep.32546.
[13]	CZIGANY Z, PRATSCHKE J, FRONĚK J, et al. Hypothermic oxygenated machine perfusion reduces early allograft injury and improves post-transplant outcomes in extended criteria donation liver transplantation from donation after brain death: results from a multicenter randomized controlled trial (HOPE ECD-DBD)[J]. Ann Surg, 2021, 274(5): 705-712. DOI: 10.1097/SLA.0000000000005110.
[14]	SCHLEGEL A, MULLER X, KALISVAART M, et al. Outcomes of DCD liver transplantation using organs treated by hypothermic oxygenated perfusion before implantation[J]. J Hepatol, 2019, 70(1): 50-57. DOI: 10.1016/j.jhep.2018.10.005.
[15]	MARTINS PN, BUCHWALD JE, MERGENTAL H, et al. The role of normothermic machine perfusion in liver transplantation[J]. Int J Surg, 2020, 82S: 52-60. DOI: 10.1016/j.ijsu.2020.05.026.
[16]	NASRALLA D, COUSSIOS CC, MERGENTAL H, et al. A randomized trial of normothermic preservation in liver transplantation[J]. Nature, 2018, 557(7703): 50-56. DOI: 10.1038/s41586-018-0047-9.
[17]	WATSON CJE, HUNT F, MESSER S, et al. In situ normothermic perfusion of livers in controlled circulatory death donation may prevent ischemic cholangiopathy and improve graft survival[J]. Am J Transplant, 2019, 19(6): 1745-1758. DOI: 10.1111/ajt.15241.
[18]	HESSHEIMER AJ, COLL E, TORRES F, et al. Normothermic regional perfusion vs. super-rapid recovery in controlled donation after circulatory death liver transplantation[J]. J Hepatol, 2019, 70(4): 658-665. DOI: 10.1016/j.jhep.2018.12.013.
[19]	GAURAV R, BUTLER AJ, KOSMOLIAPTSIS V, et al. Liver transplantation outcomes from controlled circulatory death donors: SCS vs in situ NRP vs ex situ NMP[J]. Ann Surg, 2022, 275(6): 1156-1164. DOI: 10.1097/SLA.0000000000005428.
[20]	RUIZ P, GASTACA M, BUSTAMANTE FJ, et al. Favorable outcomes after liver transplantation with normothermic regional perfusion from donors after circulatory death: a single-center experience[J]. Transplantation, 2019, 103(5): 938-943. DOI: 10.1097/TP.0000000000002391.
[21]	BOTEON YL, AFFORD SC, MERGENTAL H. Pushing the limits: machine preservation of the liver as a tool to recondition high-risk grafts[J]. Curr Transplant Rep, 2018, 5(2): 113-120. DOI: 10.1007/s40472-018-0188-7.
[22]	LINARES I, HAMAR M, SELZNER N, et al. Steatosis in liver transplantation: current limitations and future strategies[J]. Transplantation, 2019, 103(1): 78-90. DOI: 10.1097/TP.0000000000002466.
[23]	NAGRATH D, XU H, TANIMURA Y, et al. Metabolic preconditioning of donor organs: defatting fatty livers by normothermic perfusion ex vivo[J]. Metab Eng, 2009, 11(4/5): 274-283. DOI: 10.1016/j.ymben.2009.05.005.
[24]	LIU Q, NASSAR A, BUCCINI L, et al. Lipid metabolism and functional assessment of discarded human livers with steatosis undergoing 24 hours of normothermic machine perfusion[J]. Liver Transpl, 2018, 24(2): 233-245. DOI: 10.1002/lt.24972.
[25]	WANG WC, SAYEDAHMED EE, MITTAL SK. Significance of preexisting vector immunity and activation of innate responses for adenoviral vector-based therapy[J]. Viruses, 2022, 14(12): 2727. DOI: 10.3390/v14122727.
[26]	CHOWDARY P, SHAPIRO S, MAKRIS M, et al. Phase 1-2 trial of AAVS3 gene therapy in patients with hemophilia B[J]. N Engl J Med, 2022, 387(3): 237-247. DOI: 10.1056/NEJMoa2119913.
[27]	BONACCORSI-RIANI E, GILLOOLY AR, IESARI S, et al. Delivering siRNA compounds during HOPE to modulate organ function: a proof-of-concept study in a rat liver transplant model[J]. Transplantation, 2022, 106(8): 1565-1576. DOI: 10.1097/TP.0000000000004175.
[28]	TCHKONIA T, KIRKLAND JL. Aging, cell senescence, and chronic disease: emerging therapeutic strategies[J]. JAMA, 2018, 320(13): 1319-1320. DOI: 10.1001/jama.2018.12440.
[29]	LI J, PENG Q, YANG R, et al. Application of mesenchymal stem cells during machine perfusion: an emerging novel strategy for organ preservation[J]. Front Immunol, 2021, 12: 713920. DOI: 10.3389/fimmu.2021.713920.
[30]	VERSTEGEN MMA, MEZZANOTTE L, RIDWAN RY, et al. First report on ex vivo delivery of paracrine active human mesenchymal stromal cells to liver grafts during machine perfusion[J]. Transplantation, 2020, 104(1): e5-e7. DOI: 10.1097/TP.0000000000002986.
[31]	TIETJEN GT, BRACAGLIA LG, SALTZMAN WM, et al. Focus on fundamentals: achieving effective nanoparticle targeting[J]. Trends Mol Med, 2018, 24(7): 598-606. DOI: 10.1016/j.molmed.2018.05.003.
[32]	STEPHENSON BTF, BONNEY GK, LAING RW, et al. Proof of concept: liver splitting during normothermic machine perfusion[J]. J Surg Case Rep, 2018(3): rjx218. DOI: 10.1093/jscr/rjx218.
[33]	SCHLEGEL A, KALISVAART M, SCALERA I, et al. The UK DCD risk score: a new proposal to define futility in donation-after-circulatory-death liver transplantation[J]. J Hepatol, 2018, 68(3): 456-464. DOI: 10.1016/j.jhep.2017.10.034.
[34]	BHOGAL RH, MIRZA DF, AFFORD SC, et al. Biomarkers of liver injury during transplantation in an era of machine perfusion[J]. Int J Mol Sci, 2020, 21(5): 1578. DOI: 10.3390/ijms21051578.
[35]	WATSON CJE, KOSMOLIAPTSIS V, PLEY C, et al. Observations on the ex situ perfusion of livers for transplantation[J]. Am J Transplant, 2018, 18(8): 2005-2020. DOI: 10.1111/ajt.14687.

Relative Articles

Supplements(0)

Cited By

Proportional views

Proportional views

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142

Figures(1)

Get Citation

PDF

XML

Article Metrics

Article views (269) PDF downloads(87)

Liver graft preservation and functional maintenance accelerate the development of liver transplantation

doi: 10.3969/j.issn.1674-7445.2023.02.004

Abstract

References

Proportional views

Catalog

通讯作者: 陈斌, bchen63@163.com

Article Metrics

Proportional views

Related

Liver graft preservation and functional maintenance accelerate the development of liver transplantation

doi: 10.3969/j.issn.1674-7445.2023.02.004

Abstract

References

Proportional views

Catalog

通讯作者: 陈斌, bchen63@163.com

Article Metrics

Proportional views

Related

Export File

Citation

Format

Content